Podcast Index
Browse podcasts by category, open recent episodes, and download audio to listen offline.
GaiaGram - Environmental Headlines from around a planet in crisis
Kevin Gallagher
Evidence 4 Faith
Michael Lane
Bench Boost by Inorganic Ventures
Inorganic Ventures
aboutlogic
Deniz Sarikaya, Thorsten Altenkirch
Stories of the Supernatural
M.P. Pellicer
Dark Mysteries — Unsolved Mysteries. Forgotten Secrets. Unanswered Questions.
Darkest Mysteries Online
Thrilling Threads - Conspiracy Theories, Strange Phenomena, True Crime, Unsolved Mysteries, etc!
Byte & Pieces
Nat19: Jumpship Junction
Nat19
Gordon's Lebanon Weather Forecast
Gordon's Lebanon Forecast 121523
PBS Space Time
PBS
Lost Terminal
Namtao Productions
Care More Be Better: A Podcast For Sustainable Social Impact and Regeneration
Corinna Bellizzi
People’s Guide to the Cthulhu Mythos: Horror Stories, Weird Fiction, and Film Reviews
DB Spitzer/David Heath/Aunt Gore
冷门知识 | 丰富你的知识储备
_要_有_光_
Dysregulated Kids: Science-Backed Parenting Help for Behavior, Anxiety, ADHD and More
Dr. Roseann Capanna Hodge
BioSpace
BioSpace
Babylon 5: 30 Years Later
Babylon 5 30 Years Later Podcast
If/Then
Stanford GSB
Formation with John Ortberg
Become New
Frekvenca X
RTVSLO – Val 202
منوعات إسلامية
تعليم عقيدة رسول الله
SpaceTime with Stuart Gary
Stuart Gary
Beyond the Void: Philosophy & Psychology for the Modern Mind
btv
Understand All
Aaron Barlow
Space News and Weather Today – Auroras, Rocket Launches & Night Sky Viewing
Caloroga Labs Space News and Weather
New Books in Communications
Marshall Poe
The Podcast by KevinMD
Kevin Pho, MD
New Books in Science, Technology, and Society
New Books Network
New Books in Environmental Studies
Marshall Poe
VoxDev Development Economics
VoxDev.org
New Books in Psychoanalysis
Marshall Poe
The Drug Science Podcast
Drug Science
The Weather Lounge
theweatherlounge
Scholarly Communication
New Books Network
New Books in Women's History
New Books Network
New Books in Urban Studies
New Books Network
Science
BioSpace
A surprising deal from Vertex Pharmaceuticals adds to Big Pharma’s acquisitive streak as Crinetics folds into the cystic fibrosis drugmaker. Meanwhile, IPOs and venture capital raises trend upward, but mostly for deriske...
The vibe at BIO 2026 in San Diego last week was overwhelmingly positive, with attendees observing noticeable changes at the FDA and an uptick in dealmaking and IPOs. Plus, a top medical journal this week retracted a pivo...
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you’ll hear from Hakan Goker, managing director at M Ventures and Maina Bhaman, partner at Sofinnova Partners. We ex...
This year has been partly defined by a return to M&A. In the first quarter of 2026, biopharma spent nearly $47 billion in acquisitions across 19 deals, and this week, AbbVie notched another one for the second quarter, sc...
In this episode of Denatured, you'll hear from Mark Lowdell, CSO & co-founder at INmuneBio Inc. and Vishwas Seshadri, CEO & director at Abeona Therapeutics. We examine how recessive dystrophic epidermolysis bullosa serve...
Moderna’s mRNA-based flu vaccine made headlines in February when the FDA declined to even review the application. Days later, the agency reversed course, setting a decision date for August and later scheduling an advisor...
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you'll hear from Hannah Franklin, associate at Biovance Capital and Pablo Gabriel Cironi Lopez, director of life sc...
Everything came up roses for Eli Lilly at the American Diabetes Association, as the pharma boasted positive results for its new pill Foundayo and next-gen asset retatrutide—not just for weight loss but also for other ind...
In this episode of Denatured, you'll be hearing from Daniel Gil, CEO of Pelage Pharmaceuticals and Francisco Ramírez-Valle, senior vice president of immunology discovery at Eli Lilly. We dive into the long-overlooked hai...
At the American Society of Clinical Oncology (ASCO) annual meeting in Chicago this past weekend, packed plenary sessions from Revolution Medicines and Summit Therapeutics’ Chinese partner Akeso stole the show. For RevMed...
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you'll be hearing from Ksenija Pavletic, partner and chief commercial officer at Jeito Capital and Thierry Laugel, m...
Eli Lilly has been as acquisitive as ever, striking five new deals in the past week alone. On Tuesday, the company dove into the deep end of vaccine development with three separate buys in the space. Outside of vaccines,...
In this episode of Denatured, as part of our series of the European life science investment ecosystem, you'll be hearing from Regina Hodits, managing director at Angelini Ventures and Sofia Ioannidou, VC partner at Ande...
FDA Commissioner Marty Makary officially resigned last week following reports of his ouster. Then, the acting directors for the agency’s two main review units also left their posts, as did the FDA chief of staff and chie...
In this episode of Denatured, you'll be hearing from Miguel Forte, president of the International Society for Cell and Gene Therapy (ISCT), and John Ellis, co-founder & CEO of Trenchant Bios, speaking live from the ISCT ...
Moments after recording this episode of The Weekly, FDA Commissioner Marty Makary announced his resignation. Reports first circulated last Friday that President Donald Trump had signed off on his ouster. The president in...
In this episode of Denatured, you'll be hearing from Georg Vo Beiske, CEO of Tribune Therapeutics and Jonas Hallén, co-founder & Chief Medical Officer of Calluna Pharma. We dive into IPF and fibrosis challenges, unpackin...
First quarter earnings continue to roll in, with Pfizer, Eli Lilly, Amgen and more reporting in the past week. While Pfizer beat consensus estimates, it wasn’t enough for analysts, who had greater expectations for the Ne...
First quarter earnings continue to roll in, with Pfizer, Eli Lilly, Amgen and more reporting in the past week. While Pfizer beat consensus estimates, it wasn’t enough for analysts, who had greater expectations for the Ne...
In this episode of Denatured, you'll be hearing from Yaniv Sneor, founder of the Mid Atlantic Bio Angels and Alex Pederson, an investor at Mid Atlantic Bio Angels and partner at Alloy Bio Consulting. We discuss why a lif...
Fill in the form below. Make sure to select both Country and Genres.
Send us a message below. We will get back to you within 24 hours.